136 related articles for article (PubMed ID: 2117858)
41. Parameters associated with Schistosoma haematobium infection before and after chemotherapy in school children from two villages in the coast province of Kenya.
Kahama AI; Vennervald BJ; Kombe Y; Kihara RW; Ndzovu M; Mungai P; Ouma JH
Trop Med Int Health; 1999 May; 4(5):335-40. PubMed ID: 10402968
[TBL] [Abstract][Full Text] [Related]
42. Single-dose metrifonate for the treatment of Schistosoma haematobium infection in an endemic area of Zimbabwe.
Mason PR; Tswana SA
Am J Trop Med Hyg; 1984 Jul; 33(4):599-601. PubMed ID: 6476204
[TBL] [Abstract][Full Text] [Related]
43. Metrifonate trial in the treatment of various presentations of Schistosoma haematobium and S. mansoni infections in the Sudan.
Omer AH; Teesdale CH
Ann Trop Med Parasitol; 1978 Apr; 72(2):145-50. PubMed ID: 352282
[TBL] [Abstract][Full Text] [Related]
44. Impact of polyparasitic infections on anemia and undernutrition among Kenyan children living in a Schistosoma haematobium-endemic area.
Bustinduy AL; Parraga IM; Thomas CL; Mungai PL; Mutuku F; Muchiri EM; Kitron U; King CH
Am J Trop Med Hyg; 2013 Mar; 88(3):433-40. PubMed ID: 23324217
[TBL] [Abstract][Full Text] [Related]
45. Patterns of Schistosoma haematobium infection, impact of praziquantel treatment and re-infection after treatment in a cohort of schoolchildren from rural KwaZulu-Natal/South Africa.
Saathoff E; Olsen A; Magnussen P; Kvalsvig JD; Becker W; Appleton CC
BMC Infect Dis; 2004 Oct; 4():40. PubMed ID: 15471549
[TBL] [Abstract][Full Text] [Related]
46. Effect of praziquantel on hematuria and proteinuria in urinary schistosomiasis.
Mott KE; Dixon H; Osei-Tutu E; England EC; Davis A
Am J Trop Med Hyg; 1985 Nov; 34(6):1119-26. PubMed ID: 3938926
[TBL] [Abstract][Full Text] [Related]
47. Efficacy of artesunate and praziquantel in Schistosoma haematobium infected schoolchildren.
De Clercq D; Vercruysse J; Kongs A; Verlé P; Dompnier JP; Faye PC
Acta Trop; 2002 Apr; 82(1):61-6. PubMed ID: 11904104
[TBL] [Abstract][Full Text] [Related]
48. Reduction in hookworm infection after praziquantel treatment among children and young adults in Leyte, the Philippines.
Shaw JG; Aggarwal N; Acosta LP; Jiz MA; Wu HW; Leenstra T; Coutinho HM; Olveda RM; Kurtis JD; McGarvey ST; Friedman JF
Am J Trop Med Hyg; 2010 Aug; 83(2):416-21. PubMed ID: 20682892
[TBL] [Abstract][Full Text] [Related]
49. Schistosoma haematobium infection and morbidity before and after large-scale administration of praziquantel in Burkina Faso.
Koukounari A; Gabrielli AF; Toure S; Bosque-Oliva E; Zhang Y; Sellin B; Donnelly CA; Fenwick A; Webster JP
J Infect Dis; 2007 Sep; 196(5):659-69. PubMed ID: 17674306
[TBL] [Abstract][Full Text] [Related]
50. The effect of a single dose of metrifonate on Schistosoma haematobium infection in Egyptian school children.
el Kholy A; Boutros S; Tamara F; Warren KS; Mahmoud AA
Am J Trop Med Hyg; 1984 Nov; 33(6):1170-2. PubMed ID: 6507729
[TBL] [Abstract][Full Text] [Related]
51. The impact of population level deworming on the haemoglobin levels of schoolchildren in Tanga, Tanzania.
Beasley NM; Tomkins AM; Hall A; Kihamia CM; Lorri W; Nduma B; Issae W; Nokes C; Bundy DA
Trop Med Int Health; 1999 Nov; 4(11):744-50. PubMed ID: 10588768
[TBL] [Abstract][Full Text] [Related]
52. Safety and efficacy of praziquantel syrup (Epiquantel®) against Schistosoma haematobium and Schistosoma mansoni in preschool-aged children in Niger.
Garba A; Lamine MS; Djibo A; Tahirou A; Aouami MA; Alfari A; Phillips AE; Fenwick A; Utzinger J
Acta Trop; 2013 Nov; 128(2):318-25. PubMed ID: 23237719
[TBL] [Abstract][Full Text] [Related]
53. Praziquantel for treatment of schistosomiasis in patients with advanced hepatosplenomegaly.
Bassily S; Farid Z; Dunn M; el-Masry NA; Stek M
Ann Trop Med Parasitol; 1985 Dec; 79(6):629-34. PubMed ID: 3938936
[TBL] [Abstract][Full Text] [Related]
54. Efficacy and safety of two closely spaced doses of praziquantel against Schistosoma haematobium and S. mansoni and re-infection patterns in school-aged children in Niger.
Garba A; Lamine MS; Barkiré N; Djibo A; Sofo B; Gouvras AN; Labbo R; Sebangou H; Webster JP; Fenwick A; Utzinger J
Acta Trop; 2013 Nov; 128(2):334-44. PubMed ID: 22940014
[TBL] [Abstract][Full Text] [Related]
55. Age-targeted chemotherapy for control of urinary schistosomiasis in endemic populations.
King CH; Muchiri EM; Ouma JH
Mem Inst Oswaldo Cruz; 1992; 87 Suppl 4():203-10. PubMed ID: 1343896
[TBL] [Abstract][Full Text] [Related]
56. Study of some aspects of cell mediated immune response in bilharzial children on a field level.
el-Hawey AM; Massoud AM; el-Rakieby A; Royzeik MS; Nassar MO
J Egypt Soc Parasitol; 1991 Aug; 21(2):411-6. PubMed ID: 1908498
[TBL] [Abstract][Full Text] [Related]
57. Poor patient compliance reduces the efficacy of metrifonate treatment of Schistosoma haematobium in Somalia.
Aden Abdi Y; Gustafsson LL
Eur J Clin Pharmacol; 1989; 36(2):161-4. PubMed ID: 2498106
[TBL] [Abstract][Full Text] [Related]
58. Efficacy and safety of mefloquine, artesunate, mefloquine-artesunate, and praziquantel against Schistosoma haematobium: randomized, exploratory open-label trial.
Keiser J; N'Guessan NA; Adoubryn KD; Silué KD; Vounatsou P; Hatz C; Utzinger J; N'Goran EK
Clin Infect Dis; 2010 May; 50(9):1205-13. PubMed ID: 20350194
[TBL] [Abstract][Full Text] [Related]
59. Efficacy and Safety of Moxidectin, Synriam, Synriam-Praziquantel versus Praziquantel against Schistosoma haematobium and S. mansoni Infections: A Randomized, Exploratory Phase 2 Trial.
Barda B; Coulibaly JT; Puchkov M; Huwyler J; Hattendorf J; Keiser J
PLoS Negl Trop Dis; 2016 Sep; 10(9):e0005008. PubMed ID: 27636542
[TBL] [Abstract][Full Text] [Related]
60. Combined Schistosoma mansoni and Schistosoma haematobium infection.
Mahmood A; Yasir M
J Coll Physicians Surg Pak; 2005 Jul; 15(7):443-4. PubMed ID: 16197880
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
